Advertisement

  • Register for Free
  • Sign In
  • My account
    Orders Downloads Address Payment methods Account details
  • SUBSCRIBE
  • About
    About
    Psychiatrist.com
    About JCP About PCC About
    CME Institute
  • SEARCH
menu arw MY ACCOUNT
  • Register for Free
  • Sign In
  • My account
    Orders Downloads Address Payment methods Account details
  • SUBSCRIBE
  • About
    About
    Psychiatrist.com
    About JCP About PCC About
    CME Institute
  • SEARCH

Error: Search field were incomplete.

psychiatrist.com logo
  • CME
  • JOURNALS
        • Journals
          • The Journal of Clinical Psychiatry
          • JCP Current Issue
          • JCP Weekly
          • JCP Archives
          • ASCP
          • The Primary Care Companion for CNS Disorders
          • PCC Current Issue
          • PCC Weekly
          • PCC Archives
  • News
  • COLLECTIONS
          • 5 Minute Pearls
          • Academic Highlights
          • Alzheimer Disease
          • ASCP Corner
          • Banner Alzheimer’s Institute
          • Childhood and Adolescent Mental Health
          • Clinical and Practical Psychopharmacology
          • Early Career Psychiatrists
          • Focus on Geriatric Psychiatry
          • Focus on Psychosis
          • Focus on Suicide
          • InfoPacks
          • Insights Videos
          • LGBTQ
          • Rare Diseases
          • Rounds in the General Hospital
          • Women’s Mental Health
  • TOPICS
        • Topics
          • Addiction
          • Anxiety
          • Bipolar Disorder
          • COVID
          • Depression (MDD)
          • Eating Disorders
          • Mood Disorders
          • Neurodevelopmental
          • Neurology
          • Obsessive-Compulsive and Related Disorders
          • Psychopharmacology
          • Schizophrenia/Schizoaffective Disorders
          • Sleep
          • Tardive Dyskinesia
          • Traumatic Brain Injury
          • See all Topics
  • FEATURES
    • Depression with Suicidal Ideation
    • MS Team Meeting
    • Schizophrenia Treatment with LAI
    • COVID Depression
    • Tardive Dyskinesia
    • The Black Physician Experience
  • For Authors
    • JCP: Submit Your Manuscript
    • JCP: Info for Authors
    • JCP: Info for Reviewers
    • PCC: Submit Your Manuscript
    • PCC: Info for Authors
    • PCC: Info for Reviewers

Error: Search field were incomplete.

Topics

A

  • Addiction
  • Adherence
  • Alzheimer Disease
  • Anxiety
  • Anxiolytics
  • Assessment Methods
  • Attention-Deficit/Hyperactivity Disorder
  • Autism Spectrum Disorders

B

  • Bipolar Disorder
  • Body Dysmorphic Disorder

C

  • Cancer
  • Cardiology
  • Catatonia
  • Child and Adolescent Psychiatry
  • Cognition
  • Comorbidity
  • Complementary and Alternative Medicine
  • Cost and Economics
  • COVID
  • Cross-Cultural Psychiatry

D

  • Delirium
  • Dementia
  • Depression (MDD)
  • Dermatology
  • Diagnostic Tools

E

  • Eating Disorders
  • Education
  • Electroconvulsive Therapy
  • Encephalitis
  • End-of-Life and Palliative Care
  • Epilepsy

F

  • Factitious Disorder
  • Forensics

G

  • Gastroenterology
  • Genetics
  • Geriatric

H

  • Headache
  • Hepatitis

I

  • Impulse-Control Disorders

J

  • Journal

L

  • LGBTQ

M

  • Medical
  • Medical Conditions
  • Metabolic Disorders
  • Migraine
  • Mood Disorders
  • Movement Disorders
  • Multiple Sclerosis

N

  • Neurodevelopmental
  • Neuroimaging
  • Neuroleptic Malignant Syndrome
  • Neurology

O

  • Obsessive-Compulsive and Related Disorders
  • Other Mental Disorders

P

  • Pain
  • Panic Disorder
  • Parkinson Disease
  • Patient Care
  • Personality Disorders
  • Phobic Disorders
  • Populations
  • Posttraumatic Stress Disorder
  • Premenstrual Dysphoric Disorder
  • Primary Care
  • Psychiatry
  • Psychopharmacology
  • Psychotherapy
  • Psychotic Disorders
  • Pulmonary Disease

R

  • Rare Diseases
  • Renal Disease
  • Research Methods and Statistics
  • Rheumatology

S

  • Schizophrenia/Schizoaffective Disorders
  • Seasonal Affective Disorder
  • Seizures
  • Sexual Dysfunction
  • Side Effects
  • Sleep
  • Somatoform Disorders
  • Stroke
  • Suicide

T

  • Tardive Dyskinesia
  • Trauma
  • Traumatic Brain Injury

V

  • Veterans and Military Issues
  • Violence and Aggression

W

  • Weight
  • Women

Advertisement

MOST POPULAR
BRIEF REPORT

Benzodiazepines Prescribed With and Without Opioids

This study analyzed the National Ambulatory Medical Care Survey to calculate recent change...

Prim Care Companion CNS Disord 2023;25(6):23br03583

Abid Rizvi and others
CLINICAL AND PRACTICAL PSYCHOPHARMACOLOGY

Physical Exercise and Health, 3: A Guide to Understanding What to Do, How, and Why—Part 1

Dr Andrade gives practical guidance on aspects of exercise, with a focus on current and fu...

J Clin Psychiatry 2023;84(6):23f15183

Chittaranjan Andrade

Advertisement

CASE REPORT

Psychopathological Effects of Solitary Confinement

There appears to be a correlation between solitary confinement and mental illness with var...

Prim Care Companion CNS Disord 2023;25(6):23cr03503

Gurtej Gill and others
CASE REPORT

Vinegar-Induced Disulfiram Reaction

A patient on disulfiram treatment developed erythematous plaques and papules after consump...

Prim Care Companion CNS Disord 2023;25(6):23cr03537

Eshani Pandey and others

Advertisement

Advertisement

© Copyright 2023

Physicians Postgraduate Press, Inc.
Lifelong Learning for Clinicians

  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794

  • About Psychiatrist.com
  • About The Journal of Clinical Psychiatry​
  • About The Primary Care Companion
    for CNS Disorders
  • About CME Institute
  • Advertisers
  • Media Relations
  • Contact Us
  • Customer Service
  • Reprints and Permissions
  • FAQs
  • Privacy Policy
  • Terms of Use

Error: Search field were incomplete.

Search Articles
click
Hello Pop
Baclofen, a French Exception, Seriously Harms Alcohol Use Disorder Patients Without Benefit To the Editor: Dr Andrade’s analysis of the Bacloville trial in a recent Clinical and Practical Psychopharmacology column, in which he concluded that “individualized treatment with high-dose baclofen (30-300 mg/d) may be a useful second-line approach in heavy drinkers” and that “baclofen may be particularly useful in patients with liver disease,” deserves comment.1 First, Andrade failed to recall that the first pivotal trial of baclofen, ALPADIR (NCT01738282; 320 patients, as with Bacloville), was negative (see Braillon et al2). Second, Dr Andrade should have warned readers that Bacloville’s results are most questionable, lacking robustness. Although he cited us,3 he overlooked the evidence we provided indicating that the Bacloville article4 was published without acknowledging major changes to the initial protocol, affecting the primary outcome. Coincidentally (although as skeptics, we do not believe in coincidence), the initial statistical team was changed when data were sold to the French pharmaceutical company applying for the marketing authorization in France. As Ronald H. Coase warned, “If you torture the data long enough, it will confess.”
Related Articles
Table Of Contents